JOHN MENDLEIN - 20 Jun 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for John Mendlein
Issuer symbol
OMGAQ
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 16:20:08 UTC
Previous filing
11 Jun 2024
Next filing
30 May 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 20 Jun 2024 Common Stock 25,000 $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.